Barclays Maintains Overweight on Acadia Healthcare Co, Lowers Price Target to $83
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Andrew Mok maintains an Overweight rating on Acadia Healthcare Co (NASDAQ:ACHC) but lowers the price target from $89 to $83.
August 01, 2024 | 3:50 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Barclays analyst Andrew Mok maintains an Overweight rating on Acadia Healthcare Co (NASDAQ:ACHC) but lowers the price target from $89 to $83.
The Overweight rating suggests a positive outlook, but the lowered price target indicates some concerns or adjustments in expectations. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100